🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

congratulations to my friend and colleague Dr. Julie Brahmer for her well deserved oncology heroes award presented via graffiti art #cfs23

Game day is on 12/3 at 6:30 AM CST! Watch Benjamin Levy lead a gameshow format where #LungCancer experts Charu Aggarwal, MD, MPH, FASCO, Stephen V Liu, MD, & Rebecca S. Heist, MD, MPH will compete to answer key questions about #ADCs in #NSCLC: bit.ly/ChicagoADCT #MedEd #MedTwitter #NACLC23

Abstract submission for WCLC24 in San Diego open! Look forward to seeing the latest advances in thoracic oncology as we celebrate 50 years of IASLC 9/7-9/10. Hope to see you there!

Watch Benjamin Levy, MD (Benjamin Levy), Marina Chiara Garassino, MD (Marina Garassino), Stephen V. Liu, MD (Stephen V Liu, MD), Zosia Piotrowska, MD (Zosia Piotrowska), discuss #NSCLC updates from #TTLC24 - to participate, visit: bit.ly/LungADC24T x.com/i/broadcasts/1…

Congratulations to my colleague Susan Combs Scott, MD for leading this editorial sciencedirect.com/science/articl… on the recent publication by Helena Yu. Great insights into how the ADC world is descending upon the EGFR space and the challenges that lie ahead sciencedirect.com/science/articl…

Add this online symposium on advanced #NSCLC to your calendar! Dr. Benjamin Levy and Dr. Luis Paz-Ares discuss new data on TROP2-targeted treatments and how they will impact patient outcomes. buff.ly/3JSpHPC #AnswersInCMELive #GetYourAnswersInCME #LiveCME

Sign up 🔜 for this online talk by Benjamin Levy and Luis Paz-Ares as they analyze the most recent efficacy and safety data for late-stage emerging TROP2-directed treatments in advanced NSCLC. buff.ly/3JSpHPC #AnswersInCMELive #GetYourAnswersInCME #LiveCME

Great discussion on ADCs past present and future with this all star panel Julia Rotow MD Helena Yu Zosia Piotrowska and moderator Mark Socinski. #onclive #peerexchange

Last Brooklyn Dining Club dinner - good luck Kevin in your new role at MUSC - as usual no one to tag

Beyond excited to join Dr. Julie Brahmer as co-director of the Division of Upper Aerodigestive Malignancies at Johns Hopkins Kimmel Cancer Center Johns Hopkins Medicine! Looking forward to further synergizing with our amazing Johns Hopkins Thoracic Oncology faculty and bring scientific discoveries in clinical care!

Register now for PER Chemotherapy Foundation Symposium, Nov. 13–15! Use code CFSSAP for 50% off for this #CME opportunity! Program Co-Chairs: Benjamin Levy; Tiffany Triana, MD; John Mascarenhas, MD gotoper.com/courses/chemot…

Anti Drug Conjugates represent a new way of treating thoracic, breast & gastrointestinal cancers. Despite recent successes, many ADCs failed during clinical development due to excessive toxicities & unfavorable risk-benefit profiles. In this episode of #LungCancerConsidered, host

Register for the 42nd CFS meeting in New York on November 13-15. I'm looking forward to speaking at the lung cancer session on Friday, Nov 15 - but a great agenda that covers all topics and free registration for physicians with the registration code "LIU" - details below! #CFS24

There is still time to register for PER Chemotherapy Foundation Symposium, Nov. 13–15! Use code CFSSAP for 50% off for this #CME opportunity! Program Co-Chairs: Benjamin Levy; Tiffany Triana, MD; John Mascarenhas, MD gotoper.com/courses/chemot…

CancerNetwork spoke with Benjamin P. Levy, MD, to highlight what to expect in the latest oncology developments from the 2024 Chemotherapy Foundation Symposium. #MedTwitter #oncology | Benjamin Levy cancernetwork.com/view/42nd-annu…

Wonderful overview and keynote lecture highlighting the science and therapeutics of NSCLC over the past 25 years much led by Roy Herbst - join us tomorrow for the lung section #CFS24 PER

Currently out of the office - see you next year #disneycruise ⁦Stephen V Liu, MD⁩

In a high-stakes trial of LUNG & ORDER at #TexasLung25, three "defense attorneys" will argue the best frontline EGFR therapy for mNSCLC. With a "judge" presiding and "bailiffs" keeping order, this debate will be the trial of the century! Register Now thetlcconference.com

Thanks to PRIME Education for allowing Dr. Benjamin Levy and me to discuss the rapidly evolving landscape for #EGFR NSCLC, incorporating the latest data from #ELCC25.

Treatment Algorithm series: mNSCLC w/ actionable mutations in 1L with Susan Combs Scott, MD ✅ EGFR ✅ ALK ✅ ROS1/BRAF/RET/NTRK/MetExon14 Full discussion: ⭐️ oncbrothers.com/nsclc-targeted… ⭐️ “Oncology Brothers” podcast #lcsm #OncTwitter #LungCancer OncUpdates